RAC1 and breast neoplasm: Rac1, a GTP binding protein, also triggered DNA damage repair by increased nucleotides metabolism to support neoadjuvant chemotherapy (NAC) resistant breast tumors, while silencing Rac1 expression by nanoparticles resensitized the cancer cells (Li et al., 2020).